AUM LifeTech and AUM BioTech Launch "Knockdown Coronavirus" Research Program

  • Published Month : Thursday, 07 May 2020 12:00 pm

Philadelphia-based Initiative Will Facilitate SARS-CoV-2 Research to Develop Antiviral Therapy for COVID-19 Using RNA Silencing FANA ASO Technology

The coronavirus pandemic has significantly disrupted life in most countries around the globe, causing a severe health and economic crisis. AUM LifeTech, Inc., a preclinical stage biotech company developing RNA therapeutics, and AUM BioTech, LLC, a genetic research startup, have jointly launched a research program called Knockdown Coronavirus with a goal of developing a treatment for COVID-19. Under this initiative, the two Philadelphia-based companies are offering self-delivering RNA silencing research products, powered by FANA ASO technology, to the global coronavirus research community to facilitate research and fast track therapeutic development. 

AUM LifeTech is currently working with collaborators with the goal of developing a therapy for COVID-19. AUM BioTech's next-generation gene silencing research tools have the capability to selectively knockdown RNA of the virus. Further, AUM BioTech's RNA targeting technology can be used to perform high-throughput genetic screening to identify the function of viral and host genes and help identify new targets for COVID-19 therapy development.

"We are very excited to launch this program and serve the global scientific community, which is working tirelessly to find a cure for COVID-19 in these unique and challenging times," said Veenu Aishwarya, founder and chief executive officer of AUM LifeTech, Inc. and AUM BioTech, LLC. "RNA targeting technology works by silencing (knocking down) the RNA that plays a crucial role, causing a loss of function, thus inhibiting viral replication and transmission. We are very proud to offer our RNA silencing platform, to better understand the biology of SARS-CoV-2 and its interaction with the host. Our goal is to provide our expertise and resources to facilitate COVID-19 research with a hope to develop a potential antiviral therapy for COVID-19 using our self-delivering FANA ASO technology. Additionally, we are actively seeking new alliances and invite the scientific community to partner with us to knockdown coronavirus and defeat COVID-19."

About The Insight Partners:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

A PHP Error was encountered

Severity: Warning

Message: count(): Parameter must be an array or an object that implements Countable

Filename: amp/news_details_amp.php

Line Number: 252

Backtrace:

File: /home/smartmarketnews/public_html/application/views/amp/news_details_amp.php
Line: 252
Function: _error_handler

File: /home/smartmarketnews/public_html/application/controllers/Amp_controller.php
Line: 41
Function: view

File: /home/smartmarketnews/public_html/index.php
Line: 315
Function: require_once

Smarter Decisions with Smart News

Smart Market News is committed to getting its readers the latest updates and insights on industries that help in making “smarter” business decisions. With insights and inputs from corporate decision makers, we bring you the stories of adopting innovative solutions and strategies that have been changing the world. Our editorial insights on products, solutions, companies, and adoption of best practices not only help in understanding the markets better, but also prove to be a complete package for your information needs.

media@smartmarketnews.com | sales@smartmarketnews.com

Contact Us
Visit Our Sites
© The News and Media Division of The Insight Partners 2019 | All Rights Reserved | Privacy Policy